Navigation Links
Emisphere in Medical News

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

... Co. Ltd. (Tokyo Stock Exchange: 4523) Mylan, Inc. (NYSE: MYL ) Metabolic-Endocrine Disorders Index (HHM) Drop Depomed Inc. (Nasdaq: DEPO ) emisphere Technologies Inc. (Nasdaq: EMIS ) Flamel Technologies SA ADS (Nasdaq: FLML ) Hospira Inc. (NYSE: HSP ) Human Genome Sciences, Inc. (Nasdaq: ...

Emisphere Names Adam Friedman Associates IR Agency of Record

...A) as its agency of record for Investor Relations. emisphere is a biopharmaceutical company that focuses on a u... collateral materials and roadshows. "As a 'new' emisphere continues to emerge, it is vital that we maintain ...alize enhanced stock valuation over time." About emisphere Technologies, Inc. ...
Emisphere in Medical Technology

Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology

CEDAR KNOLLS, N.J., April 16 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS ) announced today that additional preclinical in vivo studies using dogs further demonstrate that its proprietary eligen(R) technology enhances the absorption of oral B12. These data confirm in a...

Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment

... and Chief Executive Officer of Emisphere. About emisphere Technologies, Inc. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation

...roprietary, synthetic chemical compounds, known as emisphere delivery agents, sometimes called carriers. Emisph...-785-424-1053 (International). ABOUT EMISPHERE emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations

...isk's proprietary GLP-1 receptor agonists. ABOUT emisphere TECHNOLOGIES, INC. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)

...n, disabling fractures, and lost mobility. About emisphere Technologies, Inc. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Genta Receives Key Patent Related to Oral Gallium Compound G4544

...ent for diseases associated with accelerated bone loss. The lead compound in this investigational pipeline, G4544, was developed in collaboration with emisphere Technologies, Inc. (Nasdaq: EMIS ) and has completed its initial Phase 1 dose-ranging study. Results of this study will be presented at the Annual Me...

Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses

... B12 that can deliver therapeutic levels." ABOUT emisphere TECHNOLOGIES, INC. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology

...N is 871428. A slide deck will be available on the emisphere web site at the time of the call. About emisphere Technologies, Inc. emisphere Technologies, Inc. is a biopharmaceutical company ...

Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases

...edings of the upcoming annual meeting of the American Society of Hematology. G4544 is a new tablet formulation using delivery technology developed by emisphere Technologies, Inc. that enables oral absorption of the active ingredient contained in Ganite(R) (gallium nitrate injection). Ganite(R) is marketed by ...

Genta Incorporated Announces Third Quarter 2007 Financial Results

... . Initial clinical trial for G4544 opens: a new oral drug for bone disease G4544 is a new tablet formulation using delivery technology developed by emisphere Technologies, Inc. that enables oral absorption of the active ingredient contained in Ganite. This compound is a highly potent inhibitor of bone loss....
Emisphere in Biological News

New technology may prevent vitamin B12 deficient seniors and vegetarians from needing injections

...n B12 is a perfect example of the successful application of our eligen technology," said Cristina Castelli, Ph. D., AAPS expert and lead researcher at emisphere Technologies, Inc. "Our current studies have shown our oral solid formulation brings vitamin B12 absorption to a range of 7-30% without the discomfort...
Emisphere in Biological Technology

Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development

Former Organon Exec Will Help Drive Company's Commercialization of Eligen(R) Technology CEDAR KNOLLS, N.J., Aug. 19 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS ) has announced that Nicholas J. Hart has joined the company as Vice President of Strategy and Development...

Michael V. Novinski, Emisphere President/CEO Featured in the Wall Street Transcript

CEDAR KNOLLS, N.J., May 16 /PRNewswire-FirstCall/ -- Highlighting the company's expectations for the future as well as its current product pipeline, Michael V. Novinski, President and CEO of Emisphere Technologies, Inc. (Nasdaq: EMIS ), was featured in an extensive interview published recentl...

BioMed Realty Trust Expands Landmark Leases With Regeneron Pharmaceuticals

...k at Eastview campus in Tarrytown, New York, which was previously leased to emisphere Technologies, Inc. Commenting on Regeneron's lease expansion, Alan D. ...ion with the Regeneron expansion, BioMed terminated its previous lease with emisphere Technologies, Inc. which was previously scheduled to expire in 2012. BioMe...

Emisphere Announces Recruitment Phase III Study for Oral Osteoarthritis Treatment

...ibute to solving this problem, and also shows that emisphere is a valuable partner in drug development." About emisphere Technologies, Inc. emisphere is a biopharmaceutical company that focuses on a u...

Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results

...ults for the first quarter ended March 31, 2008. emisphere will host a conference call to discuss first quart...s and Canada) or 1-402-220-1346 (International). emisphere will conduct its Annual Stockholders Meeting on Th... 10:00 AM EDT. FIRST QUARTER FINANCIAL RESULTS emisphere reported a net loss of $3.9 million, or $0.13 per ...

Emisphere Technologies, Inc. Announces Conference Call for First Quarter 2008 Financial Results

...Canada) or 1-402-220-1346 (International). About emisphere Technologies, Inc. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements

...o NASDAQ's corporate governance standards. ABOUT emisphere TECHNOLOGIES, INC. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008

... The meeting will begin at 10:00 a.m. EDT. ABOUT emisphere TECHNOLOGIES, INC. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...sai Co. Ltd. (Tokyo Stock Exchange: 4523) Mylan, Inc. (NYSE: MYL ) Metabolic-Endocrine Disorders Index (HHM) Drop Depomed Inc. (Nasdaq: DEPO ) emisphere Technologies Inc. (Nasdaq: EMIS ) Flamel Technologies SA ADS (Nasdaq: FLML ) Hospira Inc. (NYSE: HSP ) Human Genome Sciences, Inc. (Nasdaq: HGS...

Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results

...fourth quarter and year ended December 31, 2007. emisphere will host a conference call to discuss fourth quar...N is 3149335. FOURTH QUARTER FINANCIAL RESULTS emisphere reported a net loss of $3.9 million, or $0.13 per ... Executive Officer. YEAR END FINANCIAL RESULTS emisphere reported a net loss of $16.9 million, or $0.58 per...
Other Tags
(Date:10/22/2014)... Shriners Hospitals for Children® and UK HealthCare ... location of Shriners Hospitals for Children - Lexington from ... University of Kentucky Albert B. Chandler Hospital. The new ... and operated by Shriners Hospitals for Children, and designed ... their families well into the future. , “The quality ...
(Date:10/22/2014)... With the Affordable Care Act (ACA) open enrollment ... Institutes for Research (AIR) finds that three out of four ... but 42 percent say they are not likely or only ... for coverage. , The AIR survey found wide gaps in ... calculate correctly how much they owe for a routine doctor’s ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Healthcare ... completing their continuing education at home or on-the-go ... access to 20 brand new, premium Seminar-on-Demand CE ... catalog of over 2,000 hours of ... customize their educational experience. With such a diverse ...
(Date:10/22/2014)... CA (PRWEB) October 22, 2014 Lintelus, ... Cormier, Sr. Vice President of Sales, will be speaking ... upcoming Meetings Technology Expo on October 28, at the ... be hosting a booth as well as a Tech ... Lintelus Meeting can create a more engaging event experience. ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... and length may be showing a genetic propensity for obesity ... genes have been linked to increased body fat, but the ... lean muscle, the researchers said. At 1 year, kids ... 2 and 3, however, these genes were linked to excessive ...
Breaking Medicine News(10 mins):Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2
(Date:10/18/2014)... patients referred for evaluation of suspected genetic conditions, ... 25 percent, including detection of a number of ... disease, according to a study appearing in ... coincide with the American Society of Human Genetics ... or coding regions of thousands of genes simultaneously ...
(Date:10/17/2014)... news release is available in German . ... millions of sperms every day in order to reproduce? And ... are the topic of the latest issue of the research ... 2014). The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld ... it is not unusual for a female to copulate with ...
(Date:10/16/2014)... body. Battles are won, lost or sometimes end ... as tumor dormancy—can last up to 25 years ... poorly understood. , A new computational model ... Professor of Chemistry at Princeton University, may help ... switch to a malignant state. Published today in ...
Breaking Biology News(10 mins):Whole-exome sequencing shows potential as diagnostic tool 2Sperm wars 2Modeling tumor dormancy 2
Other Contents